Literature DB >> 9785470

ATP7B (WND) protein.

K Terada1, M L Schilsky, N Miura, T Sugiyama.   

Abstract

Wilson's disease is a genetic disorder of copper metabolism characterized by the excessive accumulation of this metal in the liver. The gene for Wilson's disease, designated ATP7B, encodes a copper transporting P-type ATPase expressed predominantly in the liver. Over 60 disease specific mutations of ATP7B have now been reported in patients with Wilson's disease. The gene for ATP7B is approximately 80 kb and contains 21 exons that encode an approximately 7.5 kb transcript. Recent studies that focus on the structure and expression of the ATP7B protein support its role as a copper transporter involved in the intracellular trafficking of copper in hepatocytes. The introduction of functional ATP7B protein by recombinant adenovirus mediated gene delivery will be a potential approach for correcting Wilson's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9785470     DOI: 10.1016/s1357-2725(98)00073-9

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  21 in total

1.  The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients.

Authors:  Xiang-Ping Li; Ji-Ye Yin; Ying Wang; Hui He; Xi Li; Wei-Jing Gong; Juan Chen; Chen-Yue Qian; Yi Zheng; Fang Li; Tao Yin; Zhi-Cheng Gong; Bo-Ting Zhou; Yu Zhang; Ling Xiao; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Tumour Biol       Date:  2014-05-23

Review 2.  Redox cycling in iron uptake, efflux, and trafficking.

Authors:  Daniel J Kosman
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

3.  Clinical presentation and mutations in Danish patients with Wilson disease.

Authors:  Lisbeth Birk Møller; Nina Horn; Tina Dysgaard Jeppesen; John Vissing; Flemming Wibrand; Poul Jennum; Peter Ott
Journal:  Eur J Hum Genet       Date:  2011-05-25       Impact factor: 4.246

4.  Genetic analysis of 55 northern Vietnamese patients with Wilson disease: seven novel mutations in ATP7B.

Authors:  Le Anh Tuan Pham; Trong Tue Nguyen; Hoang Bich Nga Le; Dat Quoc Tran; Cam Tu Ho; Thinh Huy Tran; Van Thanh Ta; The Hung Bui; Van Khanh Tran
Journal:  J Genet       Date:  2017-12       Impact factor: 1.166

5.  Copper transportion of WD protein in hepatocytes from Wilson disease patients in vitro.

Authors:  G Q Hou; X L Liang; R Chen; L W Tang; Y Wang; P Y Xu; Y R Zhang; C H Ou
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

Review 6.  Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?

Authors:  M L Schilsky
Journal:  Curr Gastroenterol Rep       Date:  2001-02

7.  ATP7B expression is associated with in vitro sensitivity to cisplatin in non-small cell lung cancer.

Authors:  Yoshimasa Inoue; Hozumi Matsumoto; Shunsuke Yamada; Kenji Kawai; Hiroshi Suemizu; Masatoshi Gika; Iwao Takanami; Masato Nakamura; Masayuki Iwazaki
Journal:  Oncol Lett       Date:  2010-03-01       Impact factor: 2.967

Review 8.  Wilson disease.

Authors:  Cord Langner; Helmut Denk
Journal:  Virchows Arch       Date:  2004-06-17       Impact factor: 4.064

9.  Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease.

Authors:  Rosanna Squitti; Carlo C Quattrocchi; Carlo Salustri; Paolo M Rossini
Journal:  Prion       Date:  2008-01-14       Impact factor: 3.931

10.  Direct Measurement of ATP7B Peptides Is Highly Effective in the Diagnosis of Wilson Disease.

Authors:  Christopher J Collins; Fan Yi; Remwilyn Dayuha; Phi Duong; Simon Horslen; Michelle Camarata; Ayse K Coskun; Roderick H J Houwen; Tudor L Pop; Heinz Zoller; Han-Wook Yoo; Sung Won Jung; Karl H Weiss; Michael L Schilsky; Peter Ferenci; Si Houn Hahn
Journal:  Gastroenterology       Date:  2021-02-25       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.